Tag: Birmingham

Talcum Powder Lawyers Win | Talc Lawsuit Alert

Talcum Powder Lawyers Win For Ovarian Cancer Victim

J&J  Has Been Ordered to Pay $417 Million

(Reuters) – A California jury on Monday ordered Johnson & Johnson to pay $417 million to a woman who claimed she developed ovarian cancer after using the company’s talc-based products like Johnson’s Baby Powder for feminine hygiene.
The Los Angeles Superior Court jury’s verdict in favor of California resident Eva Echeverria was the largest yet in lawsuits alleging J&J failed to adequately warn consumers about the cancer risks of its talc-based products.
“We are grateful for the jury’s verdict on this matter and that Eva Echeverria was able to have her day in court,” Mark Robinson, her lawyer, said in a statement.
The verdict included $70 million in compensatory damages and $347 million in punitive damages. It was a major setback for J&J, which faces 4,800 similar claims nationally and has been hit with over $300 million in verdicts by juries in Missouri.
“We will appeal today’s verdict because we are guided by the science, which supports the safety of Johnson’s Baby Powder,” J&J said.
Echeverria’s lawsuit was the first out of hundreds of California talc cases to go to trial.
The 63-year-old claimed she developed terminal ovarian cancer after decades of using J&J’s products. Her lawyers argued J&J encouraged women to use its products despite knowing of studies linking ovarian cancer to genital talc use.
J&J’s lawyers countered that studies and federal agencies have not found that talc products are carcinogenic.
The trial follows five prior ones in Missouri state court, where many lawsuits are pending.
J&J lost four of those trials and, along with a talc supplier, has been hit with $307 million in verdicts. Before Monday, the largest verdict was for $110 million.
The Missouri cases, which have largely been brought by out-of-state plaintiffs, have faced jurisdictional questions after the U.S. Supreme Court issued a ruling in June that limited where personal injury lawsuits can be filed.
In a decision in a case involving Bristol-Myers Squibb Co, the Supreme Court said state courts cannot hear claims against companies that are not based in the state when the alleged injuries did not occur there.
The ruling prompted a St. Louis judge, at New Jersey-based J&J’s urging, to declare a mistrial in the talc case already underway.
The judge has nonetheless left the door open for the plaintiffs to argue they still have jurisdiction based on a Missouri-based bottler J&J used to package its products.
The case is Echeverria et al v. Johnson & Johnson, Los Angeles Superior Court, No. BC628228.
(Reporting by Nate Raymond in Boston; Editing by Matthew Lewis and Paul Simao)

If you or a loved one used  Johnson and Johnson Talcum Powder  products for over five years on or near the genital area and now have a diagnosis of ovarian cancer or fallopian tube cancer contact The Talcum Powder Lawyer Helpline today.

Johnson and Johnson Hernia Mesh Harming Women

Another Johnson and Johnson product is receiving adverse reports for complications and mesh failure. This product is the Johnson and Johnson Ethicon hernia mesh. In our continuing attempt to help women injured by dangerous drugs, devices and consumer products, we have lawyers filing hernia mesh lawsuits for victims.

Physiomesh Causing Complications

 

The Physiomesh is a flexible composite mesh that is used in hernia repair.  It is made from  polypropylene, the same  mesh is also used to reinforce the vaginal wall in transvaginal mesh surgery.  This the same vaginal mesh that has been falling apart in women.

Johnson and Johnson Withdraws Physiomesh

In May of 2016, Ethicon  issued a worldwide recall of Physiomesh. The recall was based on the fact that the medical product was associated with a higher risk of  complications, including the need for additional surgeries. Many women who underwent hernia repair surgeries that used Physiomesh experienced mesh failure  events.

What Are The Dangers of Physiomesh?

Abdominal pain;
Necessary revision surgery to remove Physiomesh;
Recurrence of hernia;
Infection;
Erosion;
Perforations;
Device failure;
Bowel obstruction;
Fever;
Constipation;
Mesh migration;
Mesh contraction;
Intestinal fistulae;
Sepsis;
Diarrhea; and
death.

FDA On Physiomesh

A November 2010 report notes  “tears, rips, holes in device” are reported, leading to “minimal adhesion” and removal of the mesh. A February 2012 report in which a patient, who underwent hernia repair surgery that used Physiomesh, returned one week  after surgery with complaints of vomiting, constipation, and abdominal pain and distention. The  symptoms were a result of the Physiomesh. Ethicon did issue a voluntary recall  and was not mandated by the FDA to do so.

Physiomesh Lawyers Filing Physiomesh Lawsuits

Have you had  hernia repair surgery and have experienced any symptoms of mesh failure?  Contact us for a physiomesh lawyer.

Also Accepting:

Ethicon Hernia Mesh Lawsuits

Physiomesh
Proceed
Covidien
Parietex

Atrium Hernia Mesh Lawsuits

C-Qur
Bard/ Davol Hernia Mesh Lawsuits

Visilex
Composix
Composix EX
Spermatex
3D Max
Sepramesh
Perfix Plug
Ventralex
Kugel
Cook Hernia Mesh

 

 

 

 

Talcum Powder Cancer Lawsuits Continue

Johnson and Johnson Facing Potentially  1000’s Of Ovarian Cancer Lawsuits

Johnson and Johnson won a  fourth talcum powder lawsuit but, had  three judgements of $72 million, $70 million and $55 million. Our lawyers have filed dozens of talcum powder lawsuits  on behalf of women who claim they got  ovarian cancer from Johnson & Johnson’s talcum based powders. A fifth talcum baby powder lawsuit was heard in the 22nd Circuit Court in St. Louis, Missouri, on April 10th. The jury heard the case of Lois Slemp, who alleges that she developed ovarian cancer as a result of long term use of talc powder found in feminine hygiene products made by Johnson & Johnson (J&J).

A California state court judge will convene a 5-day “Sargon” hearing, California’s equivalent of a Daubert proceeding, to determine the admissibility of expert witness testimony. This could be as significant as a trial itself, after a New Jersey state court judge in October nixed testimony from two key expert witnesses for the plaintiff, scuttling what was set to the first talcum powder trial in the state. That decision remains on appeal.

Depending on the outcome of the June hearing, a bellwether trial is scheduled for July in Los Angeles, along with another trial scheduled that same month in Washington D.C. Superior Court. .

The case is captioned Valerie Swann, et al. v. Johnson & Johnson, et al. case number 1422 CC09326-01 in Missouri’s 22nd Judicial Circuit Court.

Talcum powder cases continue in Federal court. About 134 cases are on file in the District of New Jersey Federal Court. The parties have been discussing various topics, including a protective order, a preservation order and other legal issues. A preservation order is where a plaintiff has to store physical or biological evidence for use in trials.

Johnson & Johnson reported in a recent filing with the U.S. Securities & Exchange Commission (SEC) that it has been named a defendant in at least 3,100 product liability claims. These lawsuits are claims by women that Baby Powder and Shower-to-Shower talc-based powders contributed to them getting ovarian cancer.

If you think you have a diagnosis of ovarian cancer due to your use of Baby Powder or Shower To Shower contact us today

 

Talcum Powder Dangerous and They Never Told You

The Talcum Powder Lawsuit Helpline continues to keep woman updated on the news regarding the link between Talcum Powder products and ovarian cancer. We continue to be amazed and horrified as we learn again and again THEY KNEW and never told us about this link. Didn’t anyone tell them that ovarian cancer can be fatal and destroy lives. We can lose our mothers, grandmothers, wives, daughters, friends and women we love and care about from this fatal disease.

We found this article online written by a dermatologist and would like to share it with our readers. We will be commenting as well.

Why we should all be more careful when sprinkling the talcum powder
by MiriamStoppard
Studies have linked talc to ovarian cancer, especially if used in the genital area, and it can also act as an irritant. It may feel soft and soothing but there are health risks to talc. As a dermatologist, I’ve never been keen on talcum powder. It can accumulate in skin creases and irritate, and its particles can act as an abrasive.

I’m even less happy using talcum powder on babies whose delicate skin is much more vulnerable to damage.

There was a scare a few decades back which linked talcum powder granules to bowel disease, such as ulcerative colitis and Crohn’s disease .

In 1991, Welsh scientists also ­discovered particles of talc embedded in ovarian and cervical cancers.

A report out earlier this year linked the use of talc on genitals with a 44% increase in invasive ovarian cancer among African American women.

The International Agency for Research on Cancer in 2006 also classified talcum powder as a possible human carcinogen if used in the female genital area.

But cancer is difficult to understand because it develops over a long period and can be influenced by several factors, including lifestyle, genes and environment. Talc is a natural clay mineral composed of magnesium and silicon.
Researchers have found links to ovarian cancer
Because of its softness it’s often used in cosmetic products, such as blusher, because it prevents caking and absorbs excess moisture.

It’s also added into some tablets and chewing gum. Talc residues are often found near asbestos , a known carcinogen which means manufacturers have to take strong measures to avoid contamination when it is mined.

Some women like to use the powder on their inner thighs to prevent chafing, while others sprinkle it on their underwear to stay fresh.

But in 1982, Harvard professor Dr Daniel W Cramer and his colleagues compared 215 women with ovarian cancer and 215 healthy women who served as a control group.

Women who used talcum powder were at nearly twice the risk of having ovarian cancer than non-users. Those who used it regularly on their genitals and sanitary pads were at more than three times the risk.

Why talc use might lead to cancer is not clear. Studies have shown that talc crystals can move up the genitourinary tract into the peritoneal cavity, where the ovaries are.

And because talc ­particles can set off inflammation, and inflammation plays an important role in the development of ovarian cancer – and any other cancer – could be a likely mechanism.

Now baby powder carries a warning to keep out of reach of children. And pediatricians, as well as dermatologists, discourage its use on babies, who can become ill or die after breathing in the particles.

You have been warned.

The Talcum Powder Lawsuit Helpline suggests. Cornstarch can serve the same purpose and is alot less dangerous. We continue to get calls on a daily basis from women horrified by the news of the dangers of Talcum Powder. Many have lost a loved one to ovarian cancer. Many remember having had the powder sprinkled on them as babies and have used it on their babies. The woman of America are stunned at how this household name is now a danger to their lives. If you believe your diagnosis of ovarian cancer or you have lost a loved one to this disease and it is related to daily use of Talcum Powder products we encourage you to join other woman and families in the Talcum Powder Lawsuit.

Ovarian Cancer? Is Talcum Powder The New Culprit?

Cervical, Ovarian, Uterine, Vaginal, Vulvar cancer are various types of gynecological cancers women must be made aware of. You must understand your risk factors and the various products on the market that can potentially cause these types of cancer. These cannot be ignored nor can the potential risk of your having used talcum powder for years.
Recently Johnson and Johnson paid  72 million dollars  to a woman’s family after she passed away from ovarian cancer. The jury accepted the claim that the  woman’s use of talcum powder products for feminine hygiene caused for her ovarian cancer and  eventual death. There are no warning  labels on Johnson and Johnson’s Baby Powder or Shower to Shower that their  these products may be harmful to women if used this way.
This is not a new idea but women have been shocked and are frightened now. If you feel ashamed talking about your private parts then realize these manufacturers used your fear of not smelling fresh to sell this product and  never told you about the ovarian cancer risk.  It has been reported that over 98,000 women have been  diagnosed with gynecologic cancers last year. Many of these were due to ovarian cancer and we do not know how many of them used the “stay dry” talcum powder marketed to them.

Do you still use talcum powder for personal hygiene?  How many other products do you use that you have no clue may harm you? The manufacturers certainly did not fess up and you obviously cannot trust them to tell you.
After the Johnson and Johnson fiasco I realized how many dangerous drugs and devices that are massive lawsuits have targeted women. We speak to women every day about the potential risk of using talcum powder and people who have lost a loved one to ovarian cancer and now realize their mother, sister grandmother, wife or loved one used these products right where the particles can travel to the ovaries.

The more I  speak with callers about their ovarian cancer and their use of talcum powder products the more I realize how careful we must be and how glad I am my mother pushed old fashioned corn starch. It was also alot cheaper in those days. But, J & J found a great market to go after. The black and Hispanic women who wanted to fit into a white society and smell clean and nice became the ultimate target.  They knew  that choosing their product, if marketed correctly, had very little to do with awareness of cancer  health, and  totally due to  fear of not smelling like a pretty white princess  all day and  every day.

Black woman often  used talcum powder  for her  their entire adult life. These products seemed safe, after all, mothers used talcum powder on their babies, right? Using Talcum Powder products were a part of being in with the other girls. Yet, as far back as 2005 Fred Hutchinson Cancer Research Center did a study  about these products. Another study   was published in 1997. The studies suggested  there might  be a connection between talcum powder use  and ovarian cancer.
Now we learn the truth thru Talcum Powder Lawsuit  TV lawyer ads.
Is there is a  connection between feminine hygiene powders and ovarian cancer? It seems that biopsies are finding talc particles in the ovaries and these particles may have been there for years. It has been noted that the constant irritation can lead to cancer producing cells. The news is out now. The Johnson and Johnson lawsuit has awakened women  across the  country. They are calling us everyday and the families that lost them to ovarian cancer are calling as well. Do you believe your ovarian cancer diagnosis is from your use of Talcum Powder? Did you lose a loved one to ovarian cancer? Did she use talcum powder daily to keep dry? Do you want to join others in the Talcum Powder lawsuit and send a message to get those bad products off the shelves? Call the Talcum Powder Lawsuit Helpline..

Taxotere Hair Loss Lawyers | Taxotere Helpline Announced

In continuing to maintain it’s role in helping women injured by dangerous drugs, devices and consumer products the Helpline ” Pink Sites” has launched a Taxotere Helpline and outreach campaign to locate all women effected by permanent hair loss after using Taxotere.

Taxotere Lawyers Filing  Hair Loss Lawsuits

In a recent Taxotere lawsuit a  woman  alleged that her use of breast cancer drug Taxotere (docetaxel) resulted in permanent alopecia, or a total failure of her hair to regrow. Sanofi-Aventis has  failed to warn patients that they may not experience hair regrowth after stopping Taxotere.

 

Taxotere Lawsuits Mount Up
In December of 2015, the U.S. Food and Drug Administration publicly announced  numerous adverse incident  reports related to Taxotere and permanent alopecia in breast cancer chemotherapy patients.

If these  filings continue  Taxotere cases may be  consolidated in federal multidistrict litigation (MDL)

 

Talcum Powder Lawyer Want Talcum Powder Off Shelves, Talcum Powder Lawsuit Helpline Agrees

Since the 72 million settlement for ovarian cancer from talcum powder hit the news Talcum Powder Lawsuit Helpline  has been inundated with calls from women requesting information on how to join the Talcum Powder – Ovarian Cancer lawsuits. They all claim they used baby powder and talcum powder products for years  as part of a keep dry “down there” routine and now they have  a diagnosis of ovarian cancer.

An Attorney Wants J&J’s Talcum Powder off Store Shelves and  So Do The Talcum Powder Lawsuit Helpline Lawyers and Helpline Social Worker . According to the helpline “The manufacturers kept the dangers a secret. Women are a constant target for dollars.”
.

According to a recent Talcum Powder- Ovarian Cancer  article:

In the wake of two multi-million dollar jury verdicts, Johnson & Johnson faces another wave of lawsuits filed by women and surviving members of families who claim the company’s talcum powder caused ovarian cancer. Plaintiff’s attorneys want the drug giant to pull its iconic baby powder and other talcum products from the market.

Two juries recently found J&J liable for hiding the risk of ovarian cancer linked to its Johnson’s Baby Powder and Shower-to-Shower products. The first February verdict awarded Jackie Fox’s estate $72 million after she filed a suit in Missouri claiming talcum powder caused ovarian cancer. She died before the trial was over. Gloria Ristesund filed the ovarian cancer lawsuit that led to a $55 million award early in May.

It is time to step in. Ovarian cancer is deadly and women’s lives are at stake here. Yes, could this cripple Johnson and Johnson’s trillion  dollar industry? Maybe but, are  the lives of our wives, sisters, grandmothers, friends, aunts, and mothers worth the risk?

 

New Drug For Ovarian Cancer

The Talcum Powder Lawsuit Helpline is more then just Talcum Powder or Baby Powder lawyers. We keep you updated on the latest ovarian cancer news and treatments. We found this online and hope it helps.

New Drugs for Advanced Ovarian Cancer

In 2014, the Food and Drug Administration (FDA) approved the first of a new class of drugs, called PARP inhibitors, to treat advanced ovarian cancer (cancer that has spread beyond the ovaries and pelvic area).

The new drug, called Lynparza (olaparib), is taken as a pill.

Lynparza is recommended for women with both advanced ovarian cancer and an inherited BRCA1 or BRCA2 gene mutation who have undergone three or more previous rounds of chemo.

In a small clinical trial, about one-third of the women who got the new drug had their tumors shrink or disappear for an average of about eight months.

Talc particles from Talcum powder can travel to the ovaries and cause cancer cells. Ovarian cancer is often fatal. The manufacturers knew about the potential risks and never published a warning or added a warning label. Why? Because Talcum powder and Baby Powder is a multi million dollar industry and was marketed for adult women to use for personal hygiene to keep private areas dry.

Talc, Talcum Powder , Baby Powder Lawyers For Ovarian Cancer

Talcum Powder Lawsuit Helpline has a Network of Talc, Talcum Powder and Baby Powder lawyers. The helpline is receiving calls from woman on a daily basis between the ages of 40 and 66.  It  becomes apparent that the current  surge in ovarian cancer fit  in the exact  age groups of thousands of women who used Talcum Powder on a daily basis in the 60’s – 80’s. It also becomes apparent that the J & J focus on the Hispanic and Afro American community in their marketing can be seen in the numbers of women with an ovarian cancer diagnosis.

The  Ovarian Cancer Age Statistics
Ovarian cancer rates are highest in women aged 55-64 years. The median age at which women are diagnosed is 63, meaning that half of women are younger than 63 when diagnosed with ovarian cancer and half are older.

Explore The History

In the 1990s Johnson and Johnson increased   marketing to African-American and Hispanic women. Studies show a 44 person increased risk for epithelial ovarian cancer with genital talc use among African-American women.  Imerys Talc America, the supplier of talc to Johnson and Johnson, has carried a warning label against genital use on its 2,000-pound supply bags since 2006.

About Talc

Talc is  a mineral substance that’s either mined or produced. It  is used in different  cosmetic and beauty products. It can be found in baby powders.  It can sometimes be contaminated with asbestos. There are many company’s now manufacturing talc free products for a reason.  Even Johnson & Johnson  has been manufacturing new ” safe”  products with cornstarch, silk powders, and finely milled oats.

Symptoms Of  Ovarian Cancer

Abdominal distension
Urinary frequency
Abdominal pain
Postmenopausal bleeding
Loss of appetite
Rectal bleeding
Abdominal bloating

If you or a family member now has a diagnosis of ovarian cancer and used Baby Powder, Talcum Powder or Talc Powder on a daily basis contact the Talcum Powder Helpline.

Latest Research on Ovarian Cancer

The Talcum Powder Lawsuit Helpline is more then just a network of experienced Talcum Powder Lawsuit Attorneys. We offer ovarian cancer resources and updates that are found online. Below you will find some of the latest research on ovarian cancer. It is now known, that the manufacturers knew that there was a potential link between ovarian cancer and the use of Talcum Powder and Baby Powder. The jury knew it when they gave the family of a talcum powder- ovarian cancer victim $72 million.

We found this page on the latest research and offer it to our followers. We hope this helps.

Ovarian Cancer – Latest Research
Approved by the Cancer.Net Editorial Board, 04/2015

Doctors are working to learn more about ovarian cancer, ways to prevent it, how to best treat it, and how to provide the best care to people diagnosed with this disease. The following areas of research may include new options for patients through clinical trials. Always talk with your doctor about the diagnostic and treatment options best for you.

Screening For Ovarian Cancer

There are no currently effective screening methods for the general population. A screening method that estimates a woman’s risk of ovarian cancer by using her age and the results of a yearly CA-125 blood test holds promise for detecting early-stage ovarian cancer. An international study is looking into the role of serial CA-125 screening for ovarian cancer. As explained in Diagnosis, CA-125 is a substance called a tumor marker that is found in higher levels in women with ovarian cancer.

In 2012, the U.S Preventative Services Task Force released a statement saying that for the general population of women with no symptoms, screening for ovarian cancer is not helpful and may lead to harm. However, women at high risk for ovarian cancer due to family history or with a BRCA mutation(s) (see Risk Factors) are recommended to have screening with CA-125 blood tests and transvaginal ultrasound. This approach has not been proven to improve survival or detect cancers at an earlier and more curable stage.

Targeted Therapy For Ovarian Cancer

Targeted therapy is a treatment that targets the cancer’s specific genes, proteins, or the tissue environment that contributes to cancer growth and survival.

Some targeted therapy is directed towards specific genes that might be found with abnormalities in certain types of epithelial ovarian cancer. For this purpose, ovarian cancer is divided into two groups:  type I and type II.  Type II cancers are the more typical high grade serous cancers, for which standard chemotherapy has been most effective. These tumors typically are diagnosed at later stages and have mutations in TP53 and BRCA genes in the tumor.  Other mutations are rarely seen.

The BRCA mutation, even if only found in the tumor and not in the blood, may increase the effectiveness of a certain classes of drugs such as PARP inhibitors (see below).  Type I tumors include the more rare types of ovarian cancer including low grade serous, endometrioid, clear cell, and mucinous cancers.  These tumors have a variety of mutations including KRAS, BRAF, PI3KCA and PTEN, which have implications for targeted treatment. Clinical trials in these groups are ongoing.

Anti-Angiogenesis Inhibitors For Ovarian Cancer

Drugs called anti-angiogenesis inhibitors block the action of a protein called vascular endothelial growth factor (VEGF). These drugs have been shown to increase the cancer’s response to treatment and delay the time it takes for the cancer to return. VEGF promotes angiogenesis, which is the formation of new blood vessels. Because a tumor needs nutrients delivered by blood vessels to grow and spread, the goal of anti-angiogensis therapies is to “starve” the tumor. Bevacizumab (Avastin), an antibody which binds VEGF and prevents it from being active, has been shown to be effective in ovarian cancer.  FDA approval was recently given in the United States for its use in combination with selected chemotherapy for patients with platinum resistant recurrence.
PARP Inhibitors For Ovarian Cancer

Another class of drugs, called PARP inhibitors, are being evaluated for ovarian cancer.  These drugs act on DNA repair in cancer cells, making it difficult for them to replicate.  The BRCA genes (BRCA1 and BRCA2) are also normally involved in DNA repair, and a mutation in these genes interfere with this pathway function.  PARP inhibitors make it particularly difficult for cells that otherwise have a BRCA mutation to grow and divide.

The PARP inhibitor olaparib (Lynparza) has received FDA approval in the United States for recurrent disease in patients who have the inherited BRCA mutation and who have received three or more lines of chemotherapy.  In the supporting study of 137 patients with a BRCA mutation, 34% of patients experienced shrinkage in tumor for an average of 7.9 months. A very small number of patients developed secondary hematologic (blood) cancers after use of these drugs. Studies are currently underway with other PARP inhibitors, which do not all require the inherited BRCA mutation. These are being tested to see if they can keep the cancer from coming back after chemotherapy. The potential benefits and risks of PARP therapy should be discussed with your doctor.
Many other new targeted treatments are also now in clinical trials. Increasingly, doctors are learning about each patient’s individual tumor’s biology through direct molecular testing. This information may be useful in matching patients with a clinical trial for a specific targeted therapy.  Learn more about the basics of targeted therapy.

Immunotherapy For Ovarian Cancer

Immunotherapy is usually designed to boost the body’s natural defenses to fight the cancer. It uses materials made either by the body or in a laboratory to bolster, target, or restore immune system function. Researchers are currently examining whether drugs called checkpoint inhibitors may boost the immune system’s ability to destroy cancer cells.  Examples of these drugs target CTLA4 or PD-1 and have recently been shown to cause shrinkage in other cancer types such as melanoma, as well as having some activity in patients with ovarian cancer.

Cancer vaccines are another type of immunotherapy currently being tested for ovarian cancer.  In addition, some approaches called “adoptive cell therapy” take killer T cells found as part of the immune system in an individual patient and grow them in the laboratory, train them to attack certain targets such as MUC 16 (CA125) that is found on any ovarian cancer cells, and them give them back intravenously to the patient.  This approach has been tried in patients with hematologic cancers using other targets with some early success, and clinical trials are now opening for ovarian cancer.  Learn more about the basics of immunotherapy.

Hormone Therapy For Ovarian Cancer

Research is underway about the role of estrogen, androgens, and other hormones in ovarian cancer treatment. For treatment of recurrent or later-stage ovarian cancer,  the use of tamoxifen (Nolvadex, Soltamax), aromatase inhibitors, and enzalutamide (Xtandi), a blocker of the androgen receptor, is being considered.

Gene Therapy For Ovarian Cancer

One new area of research is discovering how damaged genes in ovarian cancer cells can be corrected or replaced. Researchers are studying the use of specially designed viruses that carry normal genes into the core of cancer cells and then replace the defective genes with the functional ones.

Supportive Care For Ovarian Cancer

Clinical trials are underway to find better ways of reducing symptoms and side effects of current ovarian cancer treatments, in order to improve a woman’s comfort and quality of life.

We will continue to search the net for ovarian cancer  information to help our clients. Our goal is to offer information that may help